Clinical Trial Update: Safety and Efficacy of the Lentiviral Vector in Gene Therapy of Beta-thalassemia Patients [NA]

View source ↗

Summary

The document discusses a lentiviral vector gene therapy being evaluated for beta-thalassemia. The trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia

Drugs mentioned

• Lentiviral vector gene therapy for beta-thalassemia

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Transfusion-dependent Beta-Thalassemia | NA | Status: RECRUITING